NCT06045338Recruiting
Mind Body Intervention for Long COVID-19
Mind Body Intervention for Long COVID
Source: ClinicalTrials.gov · Last updated 18 Feb 2026
Brief summary (registry, in English)
The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- First submitted
- 19 Sept 2023
- Start date
- 9 Nov 2023
- Primary completion date
- Sept 2026
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06045338
What you commit to
- Study type: Interventional
- Planned participants: 180
- From 9 Nov 2023 to the primary completion date, Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clear diagnosis of physical disease (e.g. lung fibrosis, myocarditis) not inclusive of non-specific findings such as mild arthritis
- Hospitalization in an intensive care unit for acute COVID-19 infections
- Diagnosis of dementia or similar cognitive impairment
- Active addiction disorder (e.g. cocaine) that would interfere with study participation
- Major psychiatric comorbidity (e.g., schizophrenia). Mild to moderate anxiety and depression are not considered in this category
Age
- Age greater than 65 years
Who the study is looking for
- Adult (≥ 18 years of age)
- Infection with Sars-COV2 (i. e., positive antibody, antigen, or PCR testing)
- Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc)
- A somatic symptom score ≥ 10 on the SSS-8 questionnaire with involvement of at least 3 domains
- Symptoms present at least 3 day a week for a minimum of 3 months
- Willingness to engage in a Mind-Body intervention
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beth Israel Deaconess Medical Center Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.